| Title |
Megestrol acetate for treatment of anorexia‐cachexia syndrome
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2013
|
| DOI | 10.1002/14651858.cd004310.pub3 |
| Pubmed ID | |
| Authors |
Vicente Ruiz Garcia, Eduardo López‐Briz, Rafael Carbonell Sanchis, Jose Luis Gonzalvez Perales, Sylvia Bort‐Martí |
| Abstract |
This is an updated version of a previously published review in The Cochrane Library (2005, Issue 2) on 'Megestrol acetate for the treatment of anorexia-cachexia syndrome'. Megestrol acetate (MA) is currently used to improve appetite and to increase weight in cancer-associated anorexia. In 1993, MA was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia or unexplained weight loss in patients with AIDS. The mechanism by which MA increases appetite is unknown and its effectiveness for anorexia and cachexia in neoplastic and AIDS (acquired immunodeficiency syndrome) patients is under investigation. |
X Demographics
The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | 43% |
| United States | 2 | 29% |
| Ireland | 1 | 14% |
| Unknown | 1 | 14% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 57% |
| Practitioners (doctors, other healthcare professionals) | 2 | 29% |
| Scientists | 1 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 484 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 2 | <1% |
| Spain | 2 | <1% |
| United Kingdom | 2 | <1% |
| Ireland | 1 | <1% |
| Hong Kong | 1 | <1% |
| Switzerland | 1 | <1% |
| Canada | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 473 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 68 | 14% |
| Researcher | 46 | 10% |
| Student > Bachelor | 46 | 10% |
| Student > Ph. D. Student | 44 | 9% |
| Student > Postgraduate | 42 | 9% |
| Other | 109 | 23% |
| Unknown | 129 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 181 | 37% |
| Nursing and Health Professions | 52 | 11% |
| Biochemistry, Genetics and Molecular Biology | 20 | 4% |
| Agricultural and Biological Sciences | 15 | 3% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 3% |
| Other | 55 | 11% |
| Unknown | 148 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2024.
All research outputs
#2,249,867
of 25,595,500 outputs
Outputs from Cochrane database of systematic reviews
#4,687
of 13,156 outputs
Outputs of similar age
#18,026
of 210,810 outputs
Outputs of similar age from Cochrane database of systematic reviews
#75
of 214 outputs
Altmetric has tracked 25,595,500 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,156 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 210,810 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 214 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.